PAV-05纳夫托金能有效抑制寨卡病毒在受感染细胞中的复制
Claudio Cesar Cirne-Santos1,2, Daniel Tadeu Gomes Gonzaga3, Gabriel Oliveira de Resende4
1Universidade Federal Fluminense, Instituto de Biologia, Laboratório de Virologia Molecular e Biotecnologia Marinha, 24210-200, Niterói-RJ, Brasil.
Current topics in medicinal chemistry
|January 23, 2025
概括
一种新的纳夫托基衍生物,PAV05,有效地抑制寨卡病毒 (ZIKV) 在细胞培养中的复制. 这种化合物对开发针对ZIKV和相关的黄病毒病毒的新抗病毒疗法充满希望.
科学领域:
- 病毒学 病毒学
- 药用化学 医学化学
背景情况:
- 寨卡病毒 (ZIKV) 导致吉林巴雷综合征和小头症.
- 寨卡病毒疫情迫切需要开发有效的抗病毒药物.
研究的目的:
- 为了评估纳夫托农衍生物与硫胺/硫酸盐组作为ZIKV复制抑制剂.
主要方法:
- 在初级神经元和Vero细胞中测试了PAV05.
- 评估了细胞毒性 (CC50) 和病毒抑制 (EC50).
- 研究了与利巴维林的协同效应,并进行了分析.
主要成果:
- 在Vero细胞中,PAV05表现出较低的细胞毒性 (CC50 > 290μM) 和强大的抗病毒活性 (EC50 = 0.92μM),产生高的选择性指数 (SI = 357).
- 即使在感染后16小时内服用PAV05,也保持了有效性.
- 当PAV05与利巴维林结合使用时,观察到显著的协同效应,在0.5μM时达到>90%的抑制.
- 在研究表明,PAV05可能准ZIKV NS2B-NS3蛋白质.
结论:
- PAV05显示出作为对抗ZIKV的治疗剂的巨大潜力.
- 这种化合物可能是广谱抗病毒药物开发的候选者.
相关概念视频
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


